Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
The global Clinical Trial Imaging market was valued at US$ 1477 million in 2023 and is anticipated to reach US$ 2346 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of the subjects are fully protected and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of the trial results.
Clinical trial imaging plays an important role at different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and treatment effect evaluation. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Clinical Trial Imaging 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 麻豆原创 by Application
1.3.1 Global Clinical Trial Imaging 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Imaging 麻豆原创 Perspective (2019-2030)
2.2 Global Clinical Trial Imaging Growth Trends by Region
2.2.1 Global Clinical Trial Imaging 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Trial Imaging Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Clinical Trial Imaging Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Clinical Trial Imaging 麻豆原创 Dynamics
2.3.1 Clinical Trial Imaging Industry Trends
2.3.2 Clinical Trial Imaging 麻豆原创 Drivers
2.3.3 Clinical Trial Imaging 麻豆原创 Challenges
2.3.4 Clinical Trial Imaging 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Imaging Players by Revenue
3.1.1 Global Top Clinical Trial Imaging Players by Revenue (2019-2024)
3.1.2 Global Clinical Trial Imaging Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Clinical Trial Imaging 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Trial Imaging Revenue
3.4 Global Clinical Trial Imaging 麻豆原创 Concentration Ratio
3.4.1 Global Clinical Trial Imaging 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Imaging Revenue in 2023
3.5 Global Key Players of Clinical Trial Imaging Head office and Area Served
3.6 Global Key Players of Clinical Trial Imaging, Product and Application
3.7 Global Key Players of Clinical Trial Imaging, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Imaging Breakdown Data by Type
4.1 Global Clinical Trial Imaging Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Clinical Trial Imaging Forecasted 麻豆原创 Size by Type (2025-2030)
5 Clinical Trial Imaging Breakdown Data by Application
5.1 Global Clinical Trial Imaging Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Clinical Trial Imaging Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Clinical Trial Imaging 麻豆原创 Size (2019-2030)
6.2 North America Clinical Trial Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Trial Imaging 麻豆原创 Size by Country (2019-2024)
6.4 North America Clinical Trial Imaging 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Imaging 麻豆原创 Size (2019-2030)
7.2 Europe Clinical Trial Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Trial Imaging 麻豆原创 Size by Country (2019-2024)
7.4 Europe Clinical Trial Imaging 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Imaging 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Clinical Trial Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Trial Imaging 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Trial Imaging 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Imaging 麻豆原创 Size (2019-2030)
9.2 Latin America Clinical Trial Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Trial Imaging 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Clinical Trial Imaging 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Clinical Trial Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Trial Imaging 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Clinical Trial Imaging Introduction
11.1.4 ICON Revenue in Clinical Trial Imaging Business (2019-2024)
11.1.5 ICON Recent Development
11.2 ERT
11.2.1 ERT Company Details
11.2.2 ERT Business Overview
11.2.3 ERT Clinical Trial Imaging Introduction
11.2.4 ERT Revenue in Clinical Trial Imaging Business (2019-2024)
11.2.5 ERT Recent Development
11.3 McLaren
11.3.1 McLaren Company Details
11.3.2 McLaren Business Overview
11.3.3 McLaren Clinical Trial Imaging Introduction
11.3.4 McLaren Revenue in Clinical Trial Imaging Business (2019-2024)
11.3.5 McLaren Recent Development
11.4 Bioclinica
11.4.1 Bioclinica Company Details
11.4.2 Bioclinica Business Overview
11.4.3 Bioclinica Clinical Trial Imaging Introduction
11.4.4 Bioclinica Revenue in Clinical Trial Imaging Business (2019-2024)
11.4.5 Bioclinica Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Clinical Trial Imaging Introduction
11.5.4 Parexel Revenue in Clinical Trial Imaging Business (2019-2024)
11.5.5 Parexel Recent Development
11.6 BioTelemetry
11.6.1 BioTelemetry Company Details
11.6.2 BioTelemetry Business Overview
11.6.3 BioTelemetry Clinical Trial Imaging Introduction
11.6.4 BioTelemetry Revenue in Clinical Trial Imaging Business (2019-2024)
11.6.5 BioTelemetry Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Details
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Clinical Trial Imaging Introduction
11.7.4 ProScan Imaging Revenue in Clinical Trial Imaging Business (2019-2024)
11.7.5 ProScan Imaging Recent Development
11.8 Imaging Endpoints
11.8.1 Imaging Endpoints Company Details
11.8.2 Imaging Endpoints Business Overview
11.8.3 Imaging Endpoints Clinical Trial Imaging Introduction
11.8.4 Imaging Endpoints Revenue in Clinical Trial Imaging Business (2019-2024)
11.8.5 Imaging Endpoints Recent Development
11.9 Radiant Sage
11.9.1 Radiant Sage Company Details
11.9.2 Radiant Sage Business Overview
11.9.3 Radiant Sage Clinical Trial Imaging Introduction
11.9.4 Radiant Sage Revenue in Clinical Trial Imaging Business (2019-2024)
11.9.5 Radiant Sage Recent Development
11.10 Micron, Inc.
11.10.1 Micron, Inc. Company Details
11.10.2 Micron, Inc. Business Overview
11.10.3 Micron, Inc. Clinical Trial Imaging Introduction
11.10.4 Micron, Inc. Revenue in Clinical Trial Imaging Business (2019-2024)
11.10.5 Micron, Inc. Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Details
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Clinical Trial Imaging Introduction
11.11.4 Intrinsic Imaging Revenue in Clinical Trial Imaging Business (2019-2024)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Details
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Clinical Trial Imaging Introduction
11.12.4 Median Technologies Revenue in Clinical Trial Imaging Business (2019-2024)
11.12.5 Median Technologies Recent Development
11.13 Cardiovascular Imaging Technologies
11.13.1 Cardiovascular Imaging Technologies Company Details
11.13.2 Cardiovascular Imaging Technologies Business Overview
11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Introduction
11.13.4 Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Business (2019-2024)
11.13.5 Cardiovascular Imaging Technologies Recent Development
11.14 Banook Medical
11.14.1 Banook Medical Company Details
11.14.2 Banook Medical Business Overview
11.14.3 Banook Medical Clinical Trial Imaging Introduction
11.14.4 Banook Medical Revenue in Clinical Trial Imaging Business (2019-2024)
11.14.5 Banook Medical Recent Development
11.15 IXICO
11.15.1 IXICO Company Details
11.15.2 IXICO Business Overview
11.15.3 IXICO Clinical Trial Imaging Introduction
11.15.4 IXICO Revenue in Clinical Trial Imaging Business (2019-2024)
11.15.5 IXICO Recent Development
11.16 Tigermed
11.16.1 Tigermed Company Details
11.16.2 Tigermed Business Overview
11.16.3 Tigermed Clinical Trial Imaging Introduction
11.16.4 Tigermed Revenue in Clinical Trial Imaging Business (2019-2024)
11.16.5 Tigermed Recent Development
11.17 Runda Medical
11.17.1 Runda Medical Company Details
11.17.2 Runda Medical Business Overview
11.17.3 Runda Medical Clinical Trial Imaging Introduction
11.17.4 Runda Medical Revenue in Clinical Trial Imaging Business (2019-2024)
11.17.5 Runda Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
听
听
*If Applicable.
